Causes of death in Japanese people with type 2 diabetes and factors associated with all-cause mortality from a large registry in Japan: the Japan Diabetes Complication and its prevention prospective (JDCP) study-9
Tóm tắt
We aimed to estimate the causes of death and their incidence rates and risk factors for all-cause mortality in Japanese people with type 2 diabetes using baseline data from the Japan Diabetes Complication and its Prevention (JDCP) prospective study. We analyzed a multicenter prospective cohort of 5944 Japanese people with diabetes aged 40–74 years. Causes of death were categorized as cardiac or cerebrovascular disease, malignancy, infectious disease, accident or suicide, sudden death of unknown cause, and other unknown causes. The Cox proportional hazards model was used to estimate the hazard ratio of all-cause mortality risk factors. The mean age was 61.4 years, and 39.9% of the population was female. Overall, the mortality ratio per 100,000 person-years (95% confidence interval [CI]) was 515.3 (95% CI 445.1–596.9). Malignancies are the most common cause of death among people with type 2 diabetes, accounting for 46.9% of all deaths, followed by cardiac and cerebrovascular diseases at 11.7% and infectious diseases at 3.9%. Higher mortality risk was significantly associated with older age, lower body-mass index, alcohol intake, history of hypertension, and acute myocardial infarction (AMI). The frequency of causes of death in people with type 2 diabetes identified in this study was similar to that from a recent survey on causes of death conducted by the Japan Diabetes Society. A lower body-mass index, alcohol intake, history of hypertension, and AMI were found to be associated with an increased total risk of type 2 diabetes.
Tài liệu tham khảo
Nakamura J, Kamiya H, Haneda M, Inagaki N, Tanizawa Y, Araki E, et al. Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: report of the committee on causes of death in diabetes mellitus. J Diabetes Investig. 2017;8(3):397–410.
Tajima N, Nishimura R, Izumi K, Hayashino Y, Origasa H, Noda M, et al. A large-scale, observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 2 diabetes—JDCP study1. J Japan Diabet Soc. 2015;58(5):346–57 ((in Japanese)).
Nishimura R, Izumi K, Hayashino Y, Origasa H, Noda M, Ueki K, et al. A large-scale observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 1 diabetes-JDCP study 2. Diabetol Int. 2016;7(1):4–11.
Hayashino Y, Izumi K, Okamura S, Nishimura R, Origasa H, Tajima N. Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: a Japan Diabetes Complication and its Prevention prospective study 3 (JDCP study 3). J Diabetes Investig. 2016;8(2):243–9.
Kawasaki R, Kitano S, Sato Y, Yamashita H, Nishimura R, Tajima N, et al. Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4). Diabetol Int. 2019;10(1):3–11.
Shikata K, Kodera R, Utsunomiya K, Koya D, Nishimura R, Miyamoto S, et al. Prevalence of albuminuria and renal dysfunction, and related clinical factors in Japanese patients with diabetes: the Japan diabetes complication and its prevention prospective study 5. J Diabetes Investig. 2020;11(2):325–32.
Inagaki K, Kikuchi T, Noguchi T, Mitani A, Naruse K, Matsubara T, et al. A large-scale observational study to investigate the current status of diabetic complications and their prevention in Japan (JDCP study 6): baseline dental and oral findings. Diabetol Int. 2021;12(1):52–61.
Takahara M, Katakami N, Hayashino Y, Nishimura R, Suzuki H, Shimano H, et al. Correction to: different impacts of metabolic profiles on future risk of cardiovascular disease between diabetes with and without established cardiovascular disease: the Japan diabetes complication and its prevention prospective study 7 (JDCP study 7). Acta Diabetol. 2021;59:67–8.
Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, et al. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5(12):951–64.
Sone H, Katagiri A, Ishibashi S, Abe R, Saito Y, Murase T, et al. Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res. 2002;34(9):509–15.
Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med. 1995;14(15):1707–23.
Brown ER, Ibrahim JG, DeGruttola V. A flexible B-spline model for multiple longitudinal biomarkers and survival. Biometrics. 2005;61(1):64–73.
Heinzl H, Kaider A. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed. 1997;54(3):201–8.
Sakamoto N, Hotta N, Kakuta H, Kamei I, Kimura M, Fukazawa H, et al. The features of causes of death in Japanese diabetics during the period 1971–1980. Tohoku J Exp Med. 1983;141(Suppl):631–8.
Hotta N, Nakamura J, Iwamoto Y, Ohno Y, Kasuga M, Kikkawa R, et al. Causes of death in Japanese diabetics: a questionnaire survey of 18,385 diabetics over a 10-years period. J Diabetes Investig. 2010;1(1–2):66–76.
Hotta N, Nakamura J, Iwamoto Y, Ohno Y, Kasuga M, Kikkawa K, et al. Causes of death in Japanese diabetics based on the results of a survey of 18,385 diabetics during 1991–2000-report of committee on causes of death in diabetes mellitus. J Japan Diabet Soc. 1996;39:221–36 (in Japanese).
Goto A, Takao T, Yoshida Y, Kawazu S, Iwamoto Y, Terauchi Y. Causes of death and estimated life expectancy among people with diabetes: a retrospective cohort study in a diabetes clinic. J Diabetes Investig. 2020;11(1):52–4.
Turin TC, Murakami Y, Miura K, Rumana N, Kadota A, Ohkubo T, et al. Diabetes and life expectancy among Japanese—NIPPON DATA80. Diabetes Res Clin Pract. 2012;96(2):e18–22.
Hayashino Y, Okamura S, Tsujii S, Ishii H, Diabetes D, Care Registry at Tenri Study G. Association between diabetes distress and all-cause mortality in Japanese individuals with type 2 diabetes: a prospective cohort study (Diabetes Distress and Care Registry in Tenri [DDCRT 18]). Diabetologia. 2018;61(9):1978–84.
Shima T, Uto H, Ueki K, Kohgo Y, Yasui K, Nakamura N, et al. Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients. J Gastroenterol. 2019;54(1):64–77.
Kwon Y, Kim HJ, Park S, Park YG, Cho KH. Body mass index-related mortality in patients with type 2 diabetes and heterogeneity in obesity paradox studies: a dose-response meta-analysis. PLoS One. 2017;12(1): e0168247.
Diem P, Deplazes M, Fajfr R, Bearth A, Muller B, Christ ER, et al. Effects of alcohol consumption on mortality in patients with type 2 diabetes mellitus. Diabetologia. 2003;46(11):1581–5.
Blomster JI, Zoungas S, Chalmers J, Li Q, Chow CK, Woodward M, et al. The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes. Diabetes Care. 2014;37(5):1353–9.
Sluik D, Boeing H, Bergmann MM, Schutze M, Teucher B, Kaaks R, et al. Alcohol consumption and mortality in individuals with diabetes mellitus. Br J Nutr. 2012;108(7):1307–15.